Literature DB >> 35382390

Comparison of the clinical phenotype of systemic sclerosis patients in Iran and France in two university centers.

Yannick Allanore1, Farhad Gharibdoost2, Ahmad Reza Jamshidi2, Ali Javinani2, Jérôme Avouac1, Elnaz Rastkar2, Sadid Hooshmandi2, Hoda Kavosi2.   

Abstract

Objectives: Systemic sclerosis is a severe and rare chronic auto-immune multisystem disorder characterized by vasculopathy and skin stiffness. Ethnic and geographical origin can influence the outcomes. In this study, we compared the phenotypic characteristics of Iranian and French patients.
Methods: This cross-sectional study was performed on 200 Iranian and 268 French systemic sclerosis patients. Iranian patients collected from the Iranian systemic sclerosis cohort of the Rheumatology Research Center, Shariati hospital, Tehran University of Medical Sciences. The French population was monocentric, and it was constituted by the patients included locally in the EUSTAR database in December 2016.
Results: The mean age at onset was significantly lower in Iranian patients (35.58 ± 11.68 vs 47.06 ± 13.54, p-value < 0.001). The female-to-male ratio was approximately 5.2:1 and was not different in the two populations. The prevalence of diffuse cutaneous systemic sclerosis was significantly higher in Iranian patients (60.2% vs 42.85%, p-value < 0.001). Calcinosis cutis and joint synovitis were more prevalent in French patients (p-value = 0.013, <0.001). The positivity of anti-topoisomerase antibody was higher in Iranian patients, whereas the anti-centromere antibody predominated in French cases (p-value < 0.001). Restrictive pattern of pulmonary function test was more common in Iranian patients (p-value < 0.001), while estimated pulmonary arterial pressure by echocardiography was higher in French patients (p-value < 0.001).
Conclusion: It seems that systemic sclerosis occurred in younger ages among Iranian female with the predominance of diffuse cutaneous subtype. In addition, lung interstitial disease appeared to be more prevalent and severe in Iranians than French patients.
© The Author(s) 2018.

Entities:  

Keywords:  France; Iran; Scleroderma; registries; systemic

Year:  2018        PMID: 35382390      PMCID: PMC8922647          DOI: 10.1177/2397198318809224

Source DB:  PubMed          Journal:  J Scleroderma Relat Disord        ISSN: 2397-1983


  46 in total

1.  Lung function reference values in Iranian adolescents.

Authors:  N Ahmadial; S Khamnei; M Abedinzadeh; H Najafi; M Mohammadi
Journal:  East Mediterr Health J       Date:  2006-11       Impact factor: 1.628

2.  On the operational characteristics of the Benjamini and Hochberg False Discovery Rate procedure.

Authors:  Gerwyn H Green; Peter J Diggle
Journal:  Stat Appl Genet Mol Biol       Date:  2007-10-11

3.  2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative.

Authors:  Frank van den Hoogen; Dinesh Khanna; Jaap Fransen; Sindhu R Johnson; Murray Baron; Alan Tyndall; Marco Matucci-Cerinic; Raymond P Naden; Thomas A Medsger; Patricia E Carreira; Gabriela Riemekasten; Philip J Clements; Christopher P Denton; Oliver Distler; Yannick Allanore; Daniel E Furst; Armando Gabrielli; Maureen D Mayes; Jacob M van Laar; James R Seibold; Laszlo Czirjak; Virginia D Steen; Murat Inanc; Otylia Kowal-Bielecka; Ulf Müller-Ladner; Gabriele Valentini; Douglas J Veale; Madelon C Vonk; Ulrich A Walker; Lorinda Chung; David H Collier; Mary Ellen Csuka; Barri J Fessler; Serena Guiducci; Ariane Herrick; Vivien M Hsu; Sergio Jimenez; Bashar Kahaleh; Peter A Merkel; Stanislav Sierakowski; Richard M Silver; Robert W Simms; John Varga; Janet E Pope
Journal:  Arthritis Rheum       Date:  2013-10-03

4.  Clinical differences between Thai systemic sclerosis patients with positive versus negative anti-topoisomerase I.

Authors:  Chingching Foocharoen; Prangsuporn Suwannachat; Sittichai Netwijitpan; Ajanee Mahakkanukrauh; Siraphop Suwannaroj; Ratanavadee Nanagara
Journal:  Int J Rheum Dis       Date:  2014-10-08       Impact factor: 2.454

5.  Screening for pulmonary hypertension in systemic sclerosis: the longitudinal development of tricuspid gradient in 227 consecutive patients, 1992-2001.

Authors:  R Hesselstrand; R Ekman; J Eskilsson; A Isaksson; A Scheja; A-K Ohlin; A Akesson
Journal:  Rheumatology (Oxford)       Date:  2004-11-23       Impact factor: 7.580

6.  Pulmonary arterial hypertension in Thai patients with systemic sclerosis.

Authors:  Suparaporn Wangkaew; Nuntana Kasitanon; Arintaya Phrommintikul; Waraporn Sukitawut; Ramjai Wichainun; Worawit Louthrenoo
Journal:  J Med Assoc Thai       Date:  2008-02

7.  Systemic sclerosis: demographic, clinical and serological features in 100 Iranian patients.

Authors:  Hadi Poormoghim; Alireza Salek Moghadam; Maziar Moradi-Lakeh; Mehrzad Jafarzadeh; Behnam Asadifar; Mohsen Ghelman; Elham Andalib
Journal:  Rheumatol Int       Date:  2013-01-24       Impact factor: 2.631

8.  Survival in systemic sclerosis-pulmonary arterial hypertension by serum autoantibody status in the Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma (PHAROS) Registry.

Authors:  Monique Hinchcliff; Saira Khanna; Vivien M Hsu; Jungwha Lee; Orit Almagor; Rowland W Chang; Virginia Steen; Lorinda Chung
Journal:  Semin Arthritis Rheum       Date:  2015-06-19       Impact factor: 5.532

Review 9.  The EULAR Scleroderma Trials and Research Group (EUSTAR): an international framework for accelerating scleroderma research.

Authors:  Alan Tyndall; Ulf M Ladner; Marco Matucci-Cerinic
Journal:  Curr Opin Rheumatol       Date:  2008-11       Impact factor: 5.006

10.  Clinical and serological features of systemic sclerosis in a multicenter African American cohort: Analysis of the genome research in African American scleroderma patients clinical database.

Authors:  Nadia D Morgan; Ami A Shah; Maureen D Mayes; Robyn T Domsic; Thomas A Medsger; Virginia D Steen; John Varga; Mary Carns; Paula S Ramos; Richard M Silver; Elena Schiopu; Dinesh Khanna; Vivien Hsu; Jessica K Gordon; Heather Gladue; Lesley A Saketkoo; Lindsey A Criswell; Chris T Derk; Marcin A Trojanowski; Victoria K Shanmugam; Lorinda Chung; Antonia Valenzuela; Reem Jan; Avram Goldberg; Elaine F Remmers; Daniel L Kastner; Fredrick M Wigley; Pravitt Gourh; Francesco Boin
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.